Maxim Group analyst Jason McCarthy downgrades Aridis Pharmaceuticals (NASDAQ:ARDS) from Buy to Hold.
Nvidia On The Rise, ChatGPT’s Secret Sauce And AI Cracks Ancient Code: This Week In Artificial Intelligence
From an optimistic outlook for Nvidia to the unlocking of ChatGPT's secret recipe, the week gone by was chock full of developments in AI.
